SIG Brokerage’s Krystal Biotech KRYS Stock Holding History

SIG Brokerage’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,849	Closed	-$503K	–	794
2025 Q3	$503K	Buy	+2,849	New	+$426K	0.01%	516

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG Brokerage's KRYS Position: Q4 2025 in Review

SIG Brokerage sold out of Krystal Biotech (KRYS) in Q4 2025, closing a stake of 2,849 shares — an estimated $503K sold.

SIG Brokerage first reported a position in KRYS in Q3 2025 and held it in 1 quarter. The position peaked at $503K in Q3 2025. 334 funds tracked by Wall St. Rank hold KRYS as of Q4 2025.

SIG Brokerage reported no remaining Krystal Biotech position as of Q4 2025 after selling out during the quarter.
SIG Brokerage sold 2,849 Krystal Biotech shares in Q4 2025, an estimated $503K.
SIG Brokerage first reported a position in Krystal Biotech in Q3 2025 and held it in 1 quarter.
SIG Brokerage's Krystal Biotech position peaked at $503K in Q3 2025.
334 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2025.

Based on SIG Brokerage's 13F filing for Q4 2025, filed 17 Feb 2026.